THE NICKLES GROUP, LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Biotechnology advocacy organization.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

Issues related to pharmacy benefit management reforms.

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.